K.J. Park, et al.
Phytochemistry 167 (2019) 112085
(
(
CH
4 mg), 22 (7 mg), and 25 (5 mg) were purified from subfractions B2D1
15 mg) and B2D3 (38 mg) by semipreparative HPLC (17% aqueous
4.3.2. (7R,8R)-1-(4-hydroxy-3-methoxyphenyl)propan-7,8-diol-4-O-β-D-
apiofuranosyl-(1 → 6)-O-β-D-glucopyranoside (2)
25
3
CN). Fraction B3 (0.9 g) was fractionated by an RP-C18 silica gel
Colorless gum; [α]D –107.9 (c 0.10, MeOH); UV (MeOH) λmax (log ε)
−1
column with 30% aqueous MeOH to obtain 8 subfractions (B3A–B3H).
Fraction B3B (106 mg) was subjected to Lobar-A Si gel 60
276 (2.42), 226 (2.96), 202 (3.50) nm; IR (KBr) νmax cm : 3702, 3670,
1
3399, 2956, 2868, 2835, 1352, 1054, 1011; H NMR (CD
3
OD,
500 MHz) and 13C NMR (CD
OD, 125 MHz) data, see Table 1; HRESIMS
(positive-ion mode) m/z 515.1735 [M + Na] (calcd. for C21H O13Na,
32
(
240 × 10 mm) column (CHCl
3
–MeOH–H
2
O, 3.8:1:0.1 → 1:1:0.1) to
3
+
acquire 3 subfractions (B3A1–B3A3). Compounds 9 (19 mg), 16 (3 mg),
and 20 (3 mg) were isolated upon purification of B3A1 (36 mg) and
515.1741).
B3A3 (13 mg) by semipreparative HPLC (13% aqueous CH
Fraction B3C (151 mg) was separated on Lobar-A Si gel 60
240 × 10 mm) column (CHCl –MeOH–H O, 3:1:0.1) to give 3 sub-
fractions (B3C1–B3C3). Fractions B3C1 (65 mg), B3C2 (27 mg), and
B3C3 (12 mg) were purified by semipreparative HPLC (13% aqueous
3
CN).
a
4
6
.3.3. 4-Hydroxy-1-(2-hydroxyethyl)phenyl-3-O-β-D-apiofuranosyl-(1 →
(
3
2
)-O-β-D-glucopyranoside (3)
25
Colorless gum; [α] –78.3 (c 0.10, MeOH); UV (MeOH) λmax (log ε)
D
−1
2
3
5
79 (2.44), 222 (sh), 201 (3.37) nm; IR (KBr) νmax cm : 3703, 3670,
492, 3398, 2961, 2868, 2835, 1351, 1054, 1012; H NMR (CD
00 MHz) and C NMR (CD OD, 125 MHz) data, see Table 1; HRESIMS
3
CH
8 mg), 18 (4 mg), 23 (13 mg), and 29 (4 mg) were isolated upon pur-
ification of fractions B4 (27 mg), B5 (100 mg), and B6 (25 mg) through
semipreparative HPLC (17–20% aqueous CH CN), respectively.
3
CN) to yield compounds 14 (30 mg) and 27 (5 mg). Compounds 17
1
3
OD,
(
13
+
(
28
positive-ion mode) m/z 471.1473 [M + Na] (calcd. for C19H O12Na,
3
4
71.1478).
Fraction B4 (2.6 g) was subjected to RP-C18 silica gel column with 20%
aqueous MeOH to yield 10 subfractions (B4A–B3J). B4B (82 mg) was
4
.3.4. 3,5-Dihydroxy-1-(hydroxymethyl)phenyl-4-O-β-D-apiofuranosyl-
separated to silica gel column (CHCl
3 2
–MeOH–H O, 3:1:0.1) to afford 2
(1 → 6)-O-β-D-glucopyranoside (4)
subfractions (B4A–B4B) and further purified by semipreparative HPLC
2
5
Colorless gum; [α] –17.7 (c 0.10, MeOH); UV (MeOH) λmax (log ε)
D
(
(
(
6% aqueous CH
4 mg), respectively. B4D (104 mg) was purified to give 3 (3 mg) and 35
5 mg) by semipreparative HPLC (12% aqueous CH CN) after fractio-
3
CN) to afford 2 (5 mg), 4 (5 mg), 11 (7 mg), and 13
−1
2
3
74 (2.08), 226 (sh), 203 (3.35) nm; IR (KBr) νmax cm : 3702, 3669,
1
491, 3397, 2970, 2946, 2868, 2835, 1352, 1054, 1022; H NMR
3
13
(
3 3
CD OD, 500 MHz) and C NMR (CD OD, 125 MHz) data, see Table 1;
nation on
a
Lobar-A Si gel 60 (240 × 10 mm) column
+
HRESIMS (positive-ion mode) m/z 473.1267 [M + Na] (calcd. for
13Na, 473.1271).
(
(
CH
CHCl –MeOH–H O, 2:1:0.1). Fractions B4E (100 mg) and B4G
3 2
18 26
C H O
159 mg) were purified by semipreparative HPLC (9–20% aqueous
CN) to acquire compounds 33 (3 mg) and 28 (9 mg), respectively.
The EtOAc-soluble layer (11 g of 19 g) was chromatographed on a
silica gel column (EtOAc-MeOH-H O, 10:1:0.1 → 1:1:0.1) to yield 3
fractions (E1–E3). Fraction E1 (5.4 g) was further separated over a silica
gel column (CHCl –MeOH–H O, 6:1:0.1 → 1:1:0.1) to obtain 9 fractions
E1A–E1I). Fraction E1E (117 mg) was subjected to passage over a
Lobar-A RP-C18 (240 × 10 mm) column with 40% aqueous MeOH and
further purified by semipreparative HPLC (20% aqueous CH CN) to
3
4
.3.5. (+)-(8R,7′S,8′R)-6-O-β-D-glucopyranosyl lyoniresinol-9′-O-β-D-
xylopyranoside (20)
2
2
5
Colorless gum; [α] +13.2 (c 0.10, MeOH); UV (MeOH) λmax (log ε)
D
2
76 (3.82), 230 (sh), 208 (4.13) nm; CD (MeOH) λmax (Δε) 287
3
2
−
1
(
−2.75), 272 (+4.39), 241 (+5.52), 222 (−3.25); IR (KBr) νmax cm
:
(
1
3
702, 3670, 3400, 2959, 2868, 2835, 1351, 1054, 1011; H NMR
(
CD
HRESIMS (positive-ion mode) m/z 737.2625 [M + Na] (calcd. for
17Na, 737.2633).
3
OD, 500 MHz) and 13C NMR (CD
3
OD, 125 MHz) data, see Table 2;
3
+
give compound 1 (5 mg). Fraction E1F (1.4 g) was separated over an
RP-C18 silica gel column with 50% aqueous MeOH to give 5 subfrac-
tions (E1F1–E1F5). Compounds 19 (5 mg), 32 (32 mg), and 34 (5 mg)
were purified from fraction E1F3 (949 mg) by semipreparative HPLC
33 46
C H O
4.3.6. Orobol-7-O-α-L-rhamnopyranosyl-(1 → 6)-O-β-D-glucopyranoside
(28)
(
30% aqueous CH
obtained by purifying fraction E1G (260 mg) through semipreparative
HPLC (12% aqueous CH CN) after separation over an RP-C18 silica gel
3
CN). Compounds 36 (18 mg) and 37 (4 mg) were
2
5
Colorless gum; [α] –61.1 (c 0.10, MeOH); UV (MeOH) λ
max
(log ε)
D
−
1
3
290 (sh), 262 (3.66), 205 (3.91) nm; IR (KBr) νmax cm : 3702, 3670,
3492, 3396, 2970, 2946, 2868, 2835, 1351, 1054, 1022; H NMR
(CD OD, 500 MHz) and C NMR (CD OD, 125 MHz) data, see Table 2;
HRESIMS (positive-ion mode) m/z 617.1479 [M + Na] (calcd. for
1
column with 40% aqueous MeOH. Fraction E1H (734 mg) was fractio-
nated over an RP-C18 silica gel column with 35% aqueous MeOH to give
13
3
3
+
3
subfractions (E1H1–E1H3) and further purified by semipreparative
HPLC (17% aqueous CH CN) to yield compound 38 (12 mg). Fraction
3
C27H30O15Na, 617.1482).
E2 (0.7 g) was separated on an RP-C18 silica gel column with 40%
aqueous MeOH resulting in 7 subfractions (E2A–E2G). Fraction E2E
4
.4. Acid hydrolysis of compounds 1–4, 20, and 28
(
(
101 mg) was subjected to passage over
a Lobar-A Si gel 60
240 × 10 mm) column (CHCl –MeOH–H O, 5:1:0.1) to obtain 4 sub-
3
2
Compounds 1–4, 20, and 28 (each 1.0 mg) were hydrolyzed with
N HCl (1 mL) under reflux for 2 h at 90 °C. The hydrolysate was di-
fractions (E2E1–E2E4). Compounds 30 (4 mg) and 31 (8 mg) were
isolated by purifying subfraction B2E2 (20 mg) through semi-
preparative HPLC (28% aqueous CH CN). Fraction E3 (1.8 g) was
3
chromatographed on an RP-C18 silica gel column with 40% aqueous
1
2
luted with H O and extracted with EtOAc. The organic layer was re-
moved under reduced pressure to give aglycone (2a–4a, 20a, and 28a),
respectively.
MeOH to give 6 subfractions (E3A–E3F). The subfraction E3B (1.2 g)
was purified by semipreparative HPLC (17% aqueous CH
compound 24 (8 mg).
3
CN) to yield
4
.4.1. (7R,8R)-1-(4-hydroxy-3-methoxyphenyl)propan-7,8-diol (2a)
25
1
Brownish gum; [α] –47.4 (c 0.05, MeOH); H NMR (CD
3
OD,
D
7
00 MHz) δ 6.78 (1H, d, J = 1.9 Hz), 6.75 (1H, d, J = 8.0 Hz), 6.65
(
1H, dd, J = 8.0, 1.9 Hz), 3.91 (1H, d, J = 6.8 Hz), 3.65 (1H, overlap),
4
.3.1. 3,5-Dihydroxyphenyl-(6′-O-benzoyl)-1-O-β-D-glucopyranoside (1)
25
0.90 (3H, d, J = 7.2 Hz).
Colorless gum; [α] –56.5 (c 0.10, MeOH); UV (MeOH) λmax (log ε)
D
−1
2
3
5
72 (2.23), 226 (3.13), 205 (3.54) nm; IR (KBr) νmax cm : 3702, 3670,
1
394, 2970, 2868, 2835, 1351, 1054, 1022; H NMR (CD
3
OD,
4.4.2. 4-Hydroxy-1-(2-hydroxyethyl)phenol (3a)
1
3
1
00 MHz) and C NMR (CD
3
OD, 125 MHz) data, see Table 1; HRESIMS
Brownish gum;
H NMR (CD OD, 700 MHz) δ 6.69 (1H, d,
3
+
(
4
positive-ion mode) m/z 415.1004 [M + Na] (calcd. for C19
15.1005).
H
20
O
9
Na,
J = 8.0 Hz), 6.67 (1H, d, J = 2.0 Hz), 6.54 (1H, dd, J = 8.0, 2.0 Hz),
3.69 (2H, t, J = 7.3 Hz), 2.68 (2H, t, J = 7.3 Hz).
6